Vnitr Lek 2005, 51(3):282-285

Současná infekce viry hepatitidy B a C - terapeutický problém nejen u starších pacientů - editorial

P. Husa
Klinika infekčních chorob Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta doc. MUDr. Petr Husa, CSc.

Received: June 22, 2004; Published: March 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Husa P. Současná infekce viry hepatitidy B a C - terapeutický problém nejen u starších pacientů - editorial. Vnitr Lek. 2005;51(3):282-285.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Buti M, Costa X, Valdes A et al. Study of hepatitis B virus replication and infection by other hepatitis viruses in patients with chronic hepatitis B virus infection (Spanish). Gastroenterologia y Hepatologia 2002; 25: 295-298. Go to original source... Go to PubMed...
    2. Crespo J, Lozano JL, de la Cruz F et al. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B Am J Gastroenterol 1994; 89: 1147-1151.
    3. Fattovich G, Tagger A, Brollo L et al. Hepatitis C virus infection in chronic hepatitis B carriers. J Infect Dis 1991; 163: 400-402. Go to original source... Go to PubMed...
    4. Gaeta GB, Stornaiuolo G, Precone DF et al. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J Hepatol 2003; 39: 1036-1041. Go to original source... Go to PubMed...
    5. Galský J, Husa P, Kümpel P et al. Diagnostika a léčba chronické virové hepatitidy C (HCV). Doporučený postup České hepatologické společnosti a Společnosti infekčního lékařství z roku 2002. Klin Mikrobiol Inf Lék 2003; 9: 54-56.
    6. Guptan RC, Thakur V, Raina V et al. Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses. J Gastroenterol Hepatol 1999; 14: 893-898. Go to original source... Go to PubMed...
    7. Hung CH, Lee CM, Lu SN et al. Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection. J Gastroenterol Hepatol (v tisku).
    8. Husa P, Husová L. Protivirová léčba chronických virových hepatitid ve vyšším věku. Čes Slov Gastroent Hepatol 2004; 58: 176-181.
    9. Husa P, Šperl J (koordinátoři), Galský J et al. Diagnostika a léčba chronické virové hepatitidy B. Doporučený postup České hepatologické společnosti a Společnosti infekčního lékařství - aktualizace březen 2003. Klin Mikrobiol Inf Lék 2003; 9: 51-54.
    10. Chiaramonte M, Stroffolini T, Vian A et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999; 85: 2132-2137. Go to original source...
    11. Liaw XF, Chien RN, Lin SM et al. Response of patients with dual hepatitis B virus and C virus infection to interferon therapy. J Interf Cytok Res 1997; 17: 449-452. Go to original source... Go to PubMed...
    12. Liu CJ, Chen PJ, Lai MY et al. Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients. Hepatology 2003; 37: 568-576. Go to original source... Go to PubMed...
    13. Lok ASF, McMahon BJ. Chronic hepatitis B. AASLD Practice Guideline. Hepatology 2001; 34: 1225-1241. Go to original source... Go to PubMed...
    14. Mazzella G, Saracco G, Festi D et al. Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial. Am J Gastroenterol 1999; 94: 2246-2250. Go to original source... Go to PubMed...
    15. Pontisso P, Ruvoletto MG, Fattovich G et al. Clinical and virological profiles in patients with multiple hepatitis infections. Gastroenterology 1993; 105: 1529-1533. Go to original source... Go to PubMed...
    16. Raimondo G, Pollicino T, Squadrito G. Clinical virology of hepatitis B virus infection. J Hepatol 2003; 39 (Suppl 1): S26-S30. Go to original source... Go to PubMed...
    17. Sagnelli E, Coppola N, Scolastico C et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 2000; 32: 1106-1110. Go to original source... Go to PubMed...
    18. Sato S, Shigetoshi F, Tanaka M et al. Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 1994; 21: 159-166. Go to original source... Go to PubMed...
    19. Shiratori Y, Shiina S, Zhang PY et al. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Cancer 1997; 80: 2060-2067. Go to original source...
    20. Squadrito G, Orlando ME, Pollicino T et al. Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. Am J Gastroenterol 2002; 97: 1518-1523. Go to original source... Go to PubMed...
    21. Villa E, Grottola A, Buttafoco P et al. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial. Am J Gastroenterol 2001; 96: 2973-2977. Go to original source... Go to PubMed...
    22. Villa E, Grottola A, Trande P et al. Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, anti-HCV-positive patients. Lancet 1993; 341: 1413. Go to original source... Go to PubMed...
    23. Weltman MD, Brotodihardjo A, Crewe EB et al. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and respond poorly to interferon-alpha treatment. J Viral Hepatol 1995; 2: 39-45. Go to original source... Go to PubMed...
    24. Zarski JP, Bohn B, Bastie A et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998; 28: 27-33. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.